Results 221 to 230 of about 52,050 (256)

Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research

Nature Reviews Cardiology, 2022
Bernard J Gersh, Gregg W Stone
exaly  

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

Lancet, The, 2018
Kenneth B Gordon, Bruce E Strober, Mark G Lebwohl   +2 more
exaly  

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Lancet, The, 2017
Kristian Reich, Ka Papp, Andrew Blauvelt
exaly  

Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction

Circulation, 2020
Michelle C Williams, Jacek Kwieciński, Priscilla A Mcelhinney   +2 more
exaly  

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Lancet, The, 2015
Hervé Bachelez, Peter C M Van De Kerkhof, Alexey Kubanov   +2 more
exaly  

Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque

Circulation, 2020
Zsofia Dora Drobni, Jana Taron, Amna Zafar   +2 more
exaly  

Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

Lancet, The, 2017
D Thaçi, Lisa Weibel, Sandra Philipp
exaly  

Periodontitis: a polymicrobial disruption of host homeostasis

Nature Reviews Microbiology, 2010
Richard P Darveau
exaly  

An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2017
Richard B Warren, Ulrich Mrowietz, Dagmar Wilsmann-Theis   +2 more
exaly  

A new era for understanding amyloid structures and disease

Nature Reviews Molecular Cell Biology, 2018
Matthew G Iadanza, Eric W Hewitt, Neil A Ranson   +2 more
exaly